Võrdle meetodeid

	Wellsi DVT skoor	CHA₂DS₂-VASc skoor	qSOFA skoor
Valdkond	Kliiniline hindamine	Kliiniline hindamine	Kliiniline hindamine
Perekond	Process / pipeline	Process / pipeline	Process / pipeline
Tekkeaasta	1994	2010	2016
Looja	Philip S. Wells	Gregory Y. H. Lip, Robby Nieuwlaat, et al.	Sepsis-3 Taskforce
Tüüp	Venous thromboembolism risk stratification	Atrial fibrillation stroke risk stratification	Rapid sepsis screening
Algallikas	Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546.	Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Rööpnimetused	Wells DVT Score, DVT Wells	CHA2DS2VASc, Atrial fibrillation stroke risk	Quick SOFA, qSOFA
Seotud	3	3	3
Kokkuvõte	The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients.	The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.